Clinical Trials Insight: 700014147
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2008
At a glance
- Drugs NCX 4016 (Primary)
- Indications Cancer pain; Peripheral arterial disorders; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors NicOx
- 03 Mar 2008 Status change from planning to discontinued, as reported in a NicOx media release.
- 31 Jul 2006 New trial record.